Ultraviolet Light Therapy for Systemic Lupus Erythematosus

Status unconfirmed · Phase 2

Conditions studied: Systemic Lupus Erythematosus

In brief

OBJECTIVES: I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.

Key facts

Study ID

NCT00004375

Run by

National Center for Research Resources (NCRR)

People needed

20

Starts

1991-09-01

Last updated by the study team

2005-06-24

Who can join

Age: 15 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• General Clinical Research Center and Charity Hospital (University of Louisiana) — New Orleans, Louisiana, United States (enrolling)
• Alton Ochsner Medical Foundation Hospital — New Orleans, Louisiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.